Net earnings for the first quarter were $209.6 million, a slight increase over the first period of 2011. Operating cash flow during the first quarter was $207.4 million.
The company reported 1 percent growth in both the American and European markets, along with a 10 percent growth in the Asia Pacific market. Total knee and hip sales each jumped 2 percent to $471 million and $344 million, respectively. The reconstructive market was also up 2 percent to $860 million.
However, the company’s spine business dropped 7 percent to $53 million.
More Articles on Orthopedic Devices:
Johnson & Johnson’s New CEO Speaks of Change
AlloSource Hires Dale Binke as Vice President of Marketing & Sales
LDR Holdings Appoints Robert McNamara CFO
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.